Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04937205 · ClinicalTrials.gov registry record

Motivation for Exercise and Physical Activity Adherence

A clinical trial, sponsored by University of Colorado, Denver.

Completed
Registry status
39
Enrollment target

NCT04937205: Completed study, sponsored by University of Colorado, Denver.

NCT04937205 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04937205 has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
39 participants
Enrollment target

Study Summary

The limited success of our current approaches to increase adoption and maintenance of physical activity in adults with overweight and obesity is a substantial barrier to effectively address the current obesity epidemic. This mentored F32 application addresses the significant public health issue of obesity and associated risk of major chronic diseases by using mixed methods research to optimize an innovative, theoretically based physical activity intervention designed to enhance motivation for exercise in adults with overweight and obesity.

Primary Outcome

During a 90-minute semi-structured focus group, participants were asked about their satisfaction with major aspects of the MOVE physical activity support program including: 1) MOVE content and 2) delivery of MOVE content including meeting frequency and structure for both group-based and 1:1 meetings. Participants were also asked about their overall experience with the MOVE program, things that worked well, things that did not work well, and about the most important things they learned from the M

Interventions

  • BEHAVIORAL MOVE

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2019-02-13
Est. Completion 2021-04-14
University of Colorado, Denver

1,283 total trials

What the finished NCT04937205 record still lists

NCT04937205 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which MOVE is the first listed.

NCT04937205 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04937205 about?

NCT04937205 is a clinical study titled "Motivation for Exercise and Physical Activity Adherence". The limited success of our current approaches to increase adoption and maintenance of physical activity in adults with overweight and obesity is a substantial barrier to effectively address the current obesity epidemic. This mentored F32 application addresses the significant public health issue of o...

What is the current status of trial NCT04937205?

This trial is currently completed. The enrollment target is 39 participants. The study started on 2019-02-13. Estimated completion is 2021-04-14.

What interventions are being tested in trial NCT04937205?

The interventions under investigation include: MOVE (BEHAVIORAL).

Who is sponsoring clinical trial NCT04937205?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03465592 · 39 participants · Phase 1

    Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

  • NCT03961776 · 39 participants

    Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems

  • NCT04050280 · 39 participants · Phase 2

    CLAG-GO for Patients With Persistent, Relapsed or Refractory AML

  • NCT04190862 · 39 participants · Phase 1

    E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04937205, the US trial registry maintained by the National Library of Medicine. NCT04937205 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.